Santi Nolasco
0000-0003-3995-7662
Università di Catania
36 papers found
Refreshing results…
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study
Real-World Experience with dupilumab in Severe Asthma: One year data from an Italian Named Patient Program
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
Prone positioning and noninvasive respiratory supports in acute hypoxemic respiratory failure
Omalizumab versus mepolizumab in severe asthma: a propensity score matched efficiency retrospective cohort study
High frequency chest wall oscillation use in non-cystic fibrosis bronchiectasis: a feasibility study
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
Practical considerations for Spirometry during the COVID-19 outbreak: Literature Review and Insights
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use [version 2; peer review: 2 approved]
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use
Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype
Comparability of asthma control test scores between self and physician-administered test
Missing publications? Search for publications with a matching author name.